Vivatides Therapeutics | RoundOS

Weekly digest by email

Loading companies…

Vivatides Therapeutics | RoundOS

Weekly digest by email

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
Apr 10, 2026	Series A	$54M	Apricot Capital — Role not disclosedHighLight Capital — Role not disclosedQiming Venture Partners — Role not disclosedTF Capital — Role not disclosed

Investors

Apricot CapitalSeries A HighLight CapitalSeries A Qiming Venture PartnersSeries A TF CapitalSeries A

Coverage

Apr 10, 2026Vivatides Therapeutics · Series A

Similar companies

AusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B$120M · Series C

MetriportOpen-source healthcare data infrastructure unifying patient records for clinicians$26M · Series A

ProFound TherapeuticsUses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia$35M · Strategic